References
- Rosenstock SJ, Møller MH, Larsson H, Johnsen SP, Madsen AH, Bendix J, et al. Improving quality of care in peptic ulcer bleeding: nationwide cohort study of 13,498 consecutive patients in the Danish Clinical Register of Emergency Surgery. Am J Gastroenterol 2013;108:1449–57.
- Hasselgren G, Carlsson J, Lind T, Schaffalitzky de Muckadell OB, Lundell L. Risk factors for rebleeding and fatal outcome in elderly patients with acute peptic ulcer bleeding. Eur J Gastroenterol Hepatol 1998;10:667–72.
- Kubba AK, Choudari C, Rajgopal C, Ghosh S, Palmer KR. Reduced long-term survival following major peptic ulcer haemorrhage. Br J Surg 1997;84:265–8.
- Imhof M, Epstein S, Ohmann C, Röher HD. Poor late prognosis of bleeding peptic ulcer. Langenbecks Arch Surg 2007;392:587–91.
- Hudson N, Faulkner G, Smith SJ, Langman MJ, Hawkey CJ, Logan RF. Late mortality in elderly patients surviving peptic ulcer bleeding. Gut 1995;37:177–81.
- Ruigómez A, García Rodríguez LA, Hasselgren G, Johansson S, Wallander MA. Overall mortality among patients surviving an episode of peptic ulcer bleeding. J Epidemiol Community Health 2000;54:130–3.
- Rorbaek-Madsen M, Fischer L, Thomsen H, Wara P. Late outcome of bleeding gastric ulcer. Five to eight years’ follow-up. Scand J Gastroenterol 1994;29:983–7.
- Crooks CJ, Card TR, West J. Excess long-term mortality following non-variceal upper gastrointestinal bleeding: a population-based cohort study. PLoS Med 2013;10:e1001437.
- Smart HL, Langman MJ. Late outcome of bleeding gastric ulcers. Gut 1986;27:926–8.
- Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003;54:908–14.
- Rosemurgy AS, Hart MB, Murphy CG, Albrink MH, Piazza A, Leparc GF, et al. Infection after injury: association with blood transfusion. Am Surg 1992;58:104–7.
- Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg 1996;82:197–204.
- Tartter PI, Steinberg B, Barron DM, Martinelli G. Transfusion history, T cell subsets and natural killer cytotoxicity in colorectal cancer patients. Vox Sang 1989;56:80–4.
- Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002;74:1180–6.
- Taha AS, McCloskey C, Craigen T, Angerson WJ, Shah AA, Morran CG. Mortality following blood transfusion for non-variceal upper gastrointestinal bleeding. Frontline Gastroenterol 2011;2:218–25.
- Kim JH, Jeong MH, Park IH, Choi JS, Rhee JA, Lee DH, et al. The association of socioeconomic status with three-year clinical outcomes in patients with acute myocardial infarction who underwent percutaneous coronary intervention. J Korean Med Sci 2014;29:536–43.
- Frederiksen BL, Osler M, Harling H; Danish Colorectal Cancer GroupLadelund S, Jørgensen T. The impact of socioeconomic factors on 30-day mortality following elective colorectal cancer surgery: a nationwide study. Eur J Cancer 2009;45:1248–56.
- Rosenstock SJ, Andersen LP, Rosenstock CV, Bonnevie O, Jørgensen T. Socioeconomic factors in Helicobacter pylori infection among Danish adults. Am J Public Health 1996;86:1539–44.
- Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974;2:394–7.
- Thygesen LC, Daasnes C, Thaulow I, Brønnum-Hansen H. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health 2011;39:12–16.
- World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310:2191–4.
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
- De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 2003;56:221–9.
- Available from http://www.si-folkesundhed.dk/Forskning/Generelt%20om%20forskning/Registre%20og%20follow-up%20studier/D%C3%B8ds%C3%A5rsagsregisteret.aspx. Accessed 14 October 2014.
- Statistics Denmark. Income and Wealth. 1991.
- Crooks CJ, West J, Card TR. Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding. Gastroenterology 2013;144:1384–93.
- Taha AS, Saffouri E, McCloskey C, Craigen T, Angerson WJ. Falling mortality when adjusted for comorbidity in upper gastrointestinal bleeding: relevance of multi-disciplinary case. Frontline Gastroenterol 2014;5:243–8.
- Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 2000;35:181–200.
- Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11–21.
- Hearnshaw SA, Logan RF, Palmer KR, Card TR, Travis SP, Murphy MF. Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2010;32:215–24.
- Restellini S, Kherad O, Jairath V, Martel M, Barkun AN. Red blood cell transfusion is associated with increased rebleeding in patients with nonvariceal upper gastrointestinal bleeding. Aliment Pharmacol Ther 2013;37:316–22.